期刊文献+

siRNA干扰XIAP基因对卵巢癌SKOV-3细胞生物学功能影响的研究 被引量:5

Effects of interference of XIAP by siRNA on the biological behaviors in ovarian carcinoma SKOV-3 cells
原文传递
导出
摘要 目的:采用小分子干扰RNA(siR-NA)技术沉默卵巢癌SKOV-3细胞X连锁凋亡抑制蛋白(XIAP)基因的表达,观察其对卵巢癌细胞增殖能力和凋亡的影响。方法:将XIAP siRNA转染SKOV-3细胞,MTT检测细胞增殖抑制情况,Annexin-V检测细胞凋亡率的变化,FCM法检测细胞周期变化。结果:XIAP siRNA转染后能明显抑制XIAP蛋白的表达,与其他组相比差异有统计学意义,F=63.782,P<0.05;特异性干涉组细胞的增殖能力明显低于空白对照组及非特异性干涉组,F=53.412,P<0.05;XIAP-siRNA转染组的细胞凋亡率为〔(31.54±0.62)%〕,与非特异性干涉组〔(5.34±0.38)%〕和空白对照组〔(6.73±0.46)%〕相比,差异有统计学意义,F=102.32,P<0.01。SKOV-3细胞明显阻滞在G0/G1期,与其他组相比,差异有统计学意义,P<0.01。结论:干扰XIAP基因可抑制卵巢癌SKOV-3细胞的增殖,诱导其凋亡。 OBJECTIVE: To silence the expression of XIAP in ovarian cancer cell line SKOV3 by using small interfering RNA (siRNA), and observe its effects on the proliferation and apoptosis. METHODS: The XIAP siRNA was transfected into SKOV-3 cells and the cell proliferation was evaluated using MTT assay. The apoptosis rate and cell cycle distribution were analyzed using Annexin-V and flow cytometry methods. RESULTS: XIAP siRNA significantly suppressed the expression of XIAP gene in SKOV-3 cells. The difference was significant com- pared with other groups (F=63. 782,P〈0.05). Specific group cells were slower than normal and nonspecific groups in the rate of cell proliferation (F 53. 412, P%0.05). The apoptosis percentage of interference group [(31. 54 ± 0. 62) %] was higher than that of nonspecific [(5. 34 ± 0. 38) %] and control groups ((6.73±0.46)~,(F=102.32, P〈0.01)]. After transfection XIAP-siRNA,SKOV-3 cells were arrested at G0/G1 phase. The difference was significant compared with other groups (P〈0.01 ). CONCLUSION: Silencing XIAP gene can inhibite the proliferation and induced the apoptosis of SKOV-3 cells.
出处 《中华肿瘤防治杂志》 CAS 2011年第7期506-508,520,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 国家青年科学基金(81001163) 辽宁省教育厅科学技术研究项目(2009A781)
关键词 卵巢肿瘤 SIRNA 细胞凋亡 XIAP ovarian neoplasms: small interfering RNA apoptosis XIAP
  • 相关文献

参考文献5

二级参考文献41

  • 1东星,周卫东,姜莹莹.XIAP和survivin联合检测判断乳腺癌预后的研究[J].中国普通外科杂志,2006,15(4):253-256. 被引量:2
  • 2张勇,王振宁.RNA干扰技术及其在肿瘤研究领域的进展[J].中华肿瘤防治杂志,2006,13(18):1436-1439. 被引量:11
  • 3白爱民,贾艳敏,张晓菁.siRNA为基础的RNAi在肿瘤基因治疗中的应用进展[J].中华肿瘤防治杂志,2007,14(12):953-955. 被引量:16
  • 4Fodde R, Brabletz T. Wnt/beta-catenin signaling in cancer sternness and malignant behavior[J]. Curr Opin Cell Biol,2007,19(2), 150-158.
  • 5MoonRT, Kohn AD, De FerrariG V, et al. WNT and beta- catenin signalling: diseases and therapies[J]. Nat Rev Genet, 2004, 5(9):691-701.
  • 6Staal F J, Clevers H C. WNT signalling and haematopoiesis: a WNT- WNT situation[J]. Nat Rev Immunol, 2005, 5(1):21-30.
  • 7Gilbertson R J. Medulloblastoma: signaling a change in treatment[J]. Lancet Oncol, 2004, 5(4): 209-218.
  • 8Utsuki S, Sato Y, Oka H, et al. Relationship between the expression of E-, N-eadherins and beta-catenin and tumor grade in astrocytomas[J]. J Neurooncol, 2002, 57(3) :187-192.
  • 9Sareddy G R, Panigrahi M, Challa S, et al. Activation of Wnt/ beta-catenin/Tcf signaling pathway in human astrocytomas[J]. Neurochem Int, 2009, 55(5) :307-317.
  • 10Sareddy G R, Challa S, Panigrahi M, et al. Wnt/beta-catenin/ Tel signaling pathway activation in malignant progression of rat gliomas induced by transplacental N-ethyl-N-nitrosourea exposure[J]. Neurochem Res, 2009, 34(7) :1278-1288.

共引文献60

同被引文献50

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部